India's Piramal Pharma up after FDA closes inspection of US facility

Piramal Pharma (Mumbai)

18/04/2024 05:30

** Shares of Piramal Pharma  PIRM.NS  rise as much as 4.2%
to 147.40 rupees, last up 2.1%
    ** Co says US FDA inspection of manufacturing facility at
Riverview, United States has been closed; establishment
inspection report issued
    ** PIRM on track for third straight session of gains
    ** Stock trading above its 50-, 100-, and 200-day moving
averages since early April
    ** About 2.3 mln shares change hands, half the 30-day avg 
    ** Stock up ~4% YTD, had gained 24% in 2023


 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))